Informational Meeting: The Importation of Infectious Biological Agents, Infectious Substances and Vectors; Public Webinar, 60790 [2020-21335]

Download as PDF 60790 Federal Register / Vol. 85, No. 188 / Monday, September 28, 2020 / Notices Dated: September 21, 2020. Marquita Cullom-Stott, Associate Director. for registration are found on the CDC Import Permit Program website, https:// www.cdc.gov/cpr/ipp/index.htm. Participants must register by November 30, 2020. This is a webinaronly event and there will be no on-site participation at the CDC broadcast facility. [FR Doc. 2020–21295 Filed 9–25–20; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: September 23, 2020. Sandra Cashman, Executive Secretary, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention Informational Meeting: The Importation of Infectious Biological Agents, Infectious Substances and Vectors; Public Webinar Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of public webinar. AGENCY: The Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS) is hosting a public webinar to address import permit regulations for infectious biological agents, infectious substances, and vectors. Besides the CDC, presenters for this webinar may include representatives from the Department of Transportation, Department of Agriculture and Department of Homeland Security. DATES: The webinar will be held December 3, 2020 from 11 a.m. to 4 p.m. (EST). Registration instructions are found on the HHS/CDC Import Permit Program website, https://www.cdc.gov/ cpr/ipp/index.htm. ADDRESSES: The webinar will be broadcast from the Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, Georgia 30329. FOR FURTHER INFORMATION CONTACT: Samuel S. Edwin, Director, Division of Select Agents and Toxins, CDC, 1600 Clifton Road NE, Mailstop H–21–7, Atlanta, Georgia 30329. Telephone: (404) 718–2000. SUPPLEMENTARY INFORMATION: This webinar is an opportunity for all interested parties (e.g., academic institutions; biomedical centers; commercial manufacturing facilities; federal, state, and local laboratories, including clinical and diagnostic laboratories; research facilities; exhibition facilities; and educational facilities) to obtain specific guidance and information regarding import permit regulations and shipping infectious biological materials. The webinar will also provide assistance to those interested in applying for an import permit from federal agencies within the United States. Instructions SUMMARY: VerDate Sep<11>2014 18:25 Sep 25, 2020 Jkt 250001 [FR Doc. 2020–21335 Filed 9–25–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10320] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by November 27, 2020. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: SUMMARY: PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number: CMS–P–0015A, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at https://www.cms.gov/Regulations-andGuidance/Legislation/ PaperworkReductionActof1995/PRAListing.html. 2. Call the Reports Clearance Office at (410) 786–1326. FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–10320 Health Care Reform Insurance Web Portal Under the PRA (44 U.S.C. 3501– 3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. E:\FR\FM\28SEN1.SGM 28SEN1

Agencies

[Federal Register Volume 85, Number 188 (Monday, September 28, 2020)]
[Notices]
[Page 60790]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21335]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Informational Meeting: The Importation of Infectious Biological 
Agents, Infectious Substances and Vectors; Public Webinar

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of public webinar.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), 
Department of Health and Human Services (HHS) is hosting a public 
webinar to address import permit regulations for infectious biological 
agents, infectious substances, and vectors. Besides the CDC, presenters 
for this webinar may include representatives from the Department of 
Transportation, Department of Agriculture and Department of Homeland 
Security.

DATES: The webinar will be held December 3, 2020 from 11 a.m. to 4 p.m. 
(EST). Registration instructions are found on the HHS/CDC Import Permit 
Program website, https://www.cdc.gov/cpr/ipp/index.htm.

ADDRESSES: The webinar will be broadcast from the Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Atlanta, Georgia 30329.

FOR FURTHER INFORMATION CONTACT: Samuel S. Edwin, Director, Division of 
Select Agents and Toxins, CDC, 1600 Clifton Road NE, Mailstop H-21-7, 
Atlanta, Georgia 30329. Telephone: (404) 718-2000.

SUPPLEMENTARY INFORMATION: This webinar is an opportunity for all 
interested parties (e.g., academic institutions; biomedical centers; 
commercial manufacturing facilities; federal, state, and local 
laboratories, including clinical and diagnostic laboratories; research 
facilities; exhibition facilities; and educational facilities) to 
obtain specific guidance and information regarding import permit 
regulations and shipping infectious biological materials. The webinar 
will also provide assistance to those interested in applying for an 
import permit from federal agencies within the United States. 
Instructions for registration are found on the CDC Import Permit 
Program website, https://www.cdc.gov/cpr/ipp/index.htm.
    Participants must register by November 30, 2020. This is a webinar-
only event and there will be no on-site participation at the CDC 
broadcast facility.

    Dated: September 23, 2020.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2020-21335 Filed 9-25-20; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.